Our equity capital markets team is experienced in international capital markets, delivering legal advice to a number of prominent corporations and financial institutions throughout Europe, the United States, Canada, Latin America, Asia, Australia, Africa and the Middle East.
We handle all types of ECM transactions, from niche listings to global equity offerings for large multi-nationals across our key industry sectors: financial institutions; energy, infrastructure and resources; transport; technology; life sciences and healthcare and consumer markets.
Contact us
Global Head of Corporate M&A and Securities
Email
raj.karia@nortonrosefulbright.com
Featured insights
Related services
News
Norton Rose Fulbright advises SPACSphere on proposed combination with Mobilewalla
United States | August 21, 2026
Norton Rose Fulbright advises D. Boral Capital on US$115 million IPO
Global | July 23, 2026
Norton Rose Fulbright advises IPTO on €1 billion share capital increase and ECM transaction
Greece | June 25, 2026
Norton Rose Fulbright advises Marex on SpaceX UK retail offer as part of landmark IPO
United Kingdom | June 16, 2026
Norton Rose Fulbright advises Optimi Health on US$15 million IPO and Nasdaq listing
Global | May 26, 2026
Corporate M&A heavyweights join Norton Rose Fulbright’s Dallas office
United States | May 04, 2026
Norton Rose Fulbright advises on landmark Hong Kong listing of Extreme Vision Technology
Global | March 30, 2026
Norton Rose Fulbright advises SPACSphere on proposed combination with Mobilewalla
United States | August 21, 2026
Norton Rose Fulbright advises D. Boral Capital on US$115 million IPO
Global | July 23, 2026
Norton Rose Fulbright advises IPTO on €1 billion share capital increase and ECM transaction
Greece | June 25, 2026
Norton Rose Fulbright advises Marex on SpaceX UK retail offer as part of landmark IPO
United Kingdom | June 16, 2026
Norton Rose Fulbright advises Optimi Health on US$15 million IPO and Nasdaq listing
Global | May 26, 2026
Corporate M&A heavyweights join Norton Rose Fulbright’s Dallas office
United States | May 04, 2026
Norton Rose Fulbright advises on landmark Hong Kong listing of Extreme Vision Technology
Global | March 30, 2026